PIPERAZINE A/M Trademark

Trademark Overview


On Monday, August 5, 1974, a trademark application was filed for PIPERAZINE A/M with the United States Patent and Trademark Office. The USPTO has given the PIPERAZINE A/M trademark a serial number of 73028621. The federal status of this trademark filing is EXPIRED as of Monday, September 9, 1996. This trademark is owned by WHITMOYER LABORATORIES, INC.. The PIPERAZINE A/M trademark is filed in the Pharmaceutical Products category with the following description:

WORMER FOR THE CONTROL OF INTERNAL PARASITES OF SWINE, CHICKENS AND TURKEYS

General Information


Serial Number73028621
Word MarkPIPERAZINE A/M
Filing DateMonday, August 5, 1974
Status900 - EXPIRED
Status DateMonday, September 9, 1996
Registration Number1026038
Registration DateTuesday, December 2, 1975
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


DisclaimerAPPLICANT DISCLAIMS THE WORD "PIPERAZINE" APART FROM THE MARK AS SHOWN.
Goods and ServicesWORMER FOR THE CONTROL OF INTERNAL PARASITES OF SWINE, CHICKENS AND TURKEYS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code9 - Expired
Class Status DateMonday, September 9, 1996
Primary Code005
First Use Anywhere DateWednesday, October 27, 1971
First Use In Commerce DateWednesday, October 27, 1971

Trademark Owner History


Party NameWHITMOYER LABORATORIES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMYERSTOWN, PA 17067

Trademark Events


Event DateEvent Description
Monday, September 9, 1996EXPIRED SEC. 9
Monday, January 22, 1996POST REGISTRATION ACTION CORRECTION
Monday, July 27, 1981REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.